WASHINGTON — It is the time of year every college basketball fan waits for. March Madness is right around the corner. Sixty-eight men's and women’s teams will soon have their sights on raising the ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

At a Tuesday meeting, the Office of Residential Life announced that it will shift its program and theme housing selection process to a randomized lottery, The Herald previously reported. In the days ...

Recursion, Roche, and its Genentech subsidiary have unveiled the latest product of their nearly four-year artificial intelligence (AI) drug discovery collaboration, a whole-genome map of specialized ...

Recursion Pharmaceuticals trades at a $2.65bn valuation despite slow clinical progress, high cash burn, and no late-stage assets. RXRX's AI-driven drug discovery model is ambitious, but pipeline value ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) stock is surging on Wednesday, without any news to justify the movement. Session volume stands at 69.3 million versus the average volume of 26.9 million, ...

Defense Secretary Pete Hegseth is expressing support for the Army’s termination of a program that assessed the branch’s leadership selection process. He shared on social media platform X an image of a ...

The Army has canceled its Command Assessment Program (CAP), a promotion board that factored psychological assessments and potential biases into leadership considerations. "Good riddance," Defense ...

The Army has cut a program it used in recent years to pick officers to lead battalions and brigades and select to the top enlisted leaders for those formations, the service’s Human Resources Command ...

– Company Eligible to Receive Up to $25 Million, Including an Upfront Equity Payment of $7.5 Million – – Extends Rallybio Cash Runway to Mid-2027 – NEW HAVEN, Conn.--(BUSINESS WIRE)--Rallybio ...